Nicotine metabolism mainly can take put while in the liver. Consequently, when nicotine is administered throughout the GI process, it undergoes initially-move metabolism by the liver, leading to a bioavailability of only about twenty%. This process inherently decreases the bioavailability of nicotine in the method and should trigger adverse GI resu